Glenmark, Yuhan Partner for Ryaltris, Eyes On US Trajectory

 
• By Anju Ghangurde and Jung Won Shin

Glenmark has kicked off 2019 with more regional deal-making, sealing an alliance for its investigational rhinitis asset with Yuhan in South Korea. But the outlook for the fixed-dose combination nasal spray also hinges on its US approval.

SE Asia
GLENMARK CONTINUES TO PURSUE REGIONAL LICENSING FOR SELECTED ASSETS • Source: Shutterstock

More from Business

More from Scrip